OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The controversial role of mast cells in fibrosis
Peter Bradding, Gunnar Pejler
Immunological Reviews (2018) Vol. 282, Iss. 1, pp. 198-231
Open Access | Times Cited: 113

Showing 1-25 of 113 citing articles:

Pathological mechanisms and therapeutic outlooks for arthrofibrosis
Kayley M. Usher, Sipin Zhu, Georgios Mavropalias, et al.
Bone Research (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 194

Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)
Paolo Spagnolo, Oliver Distler, Christopher J. Ryerson, et al.
Annals of the Rheumatic Diseases (2020) Vol. 80, Iss. 2, pp. 143-150
Open Access | Times Cited: 173

New perspectives on the origins and heterogeneity of mast cells
Ashley L. St. John, Abhay P. S. Rathore, Florent Ginhoux
Nature reviews. Immunology (2022) Vol. 23, Iss. 1, pp. 55-68
Closed Access | Times Cited: 71

Oxidative Stress: A Culprit in the Progression of Diabetic Kidney Disease
Na Wang, Chun Zhang
Antioxidants (2024) Vol. 13, Iss. 4, pp. 455-455
Open Access | Times Cited: 39

AKI: an increasingly recognized risk factor for CKD development and progression
Johanna T. Kurzhagen, Sergio Dellepiane, Vincenzo Cantaluppi, et al.
Journal of Nephrology (2020) Vol. 33, Iss. 6, pp. 1171-1187
Closed Access | Times Cited: 133

Type 3 cytokines IL-17A and IL-22 drive TGF-β–dependent liver fibrosis
Thomas Fabre, Manuel Flores Molina, Geneviève Soucy, et al.
Science Immunology (2018) Vol. 3, Iss. 28
Closed Access | Times Cited: 118

The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders
Jacopo Di Gregorio, Iole Robuffo, Sonia Spalletta, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 115

Mast cells as protectors of health
Anne Dudeck, Martin Köberle, Oliver Goldmann, et al.
Journal of Allergy and Clinical Immunology (2018) Vol. 144, Iss. 4, pp. S4-S18
Open Access | Times Cited: 110

The Relationship Between Hypermobile Ehlers-Danlos Syndrome (hEDS), Postural Orthostatic Tachycardia Syndrome (POTS), and Mast Cell Activation Syndrome (MCAS)
Alison H. Kucharik, Christopher Chang
Clinical Reviews in Allergy & Immunology (2019) Vol. 58, Iss. 3, pp. 273-297
Closed Access | Times Cited: 82

Mast Cells in Cardiac Fibrosis: New Insights Suggest Opportunities for Intervention
Stephanie Legere, Ian D. Haidl, Jean‐François Légaré, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 76

Oxidative stress as a culprit in diabetic kidney disease
Sensen Su, Zhanchuan Ma, Hao Wu, et al.
Life Sciences (2023) Vol. 322, pp. 121661-121661
Closed Access | Times Cited: 26

SIRT3: A potential therapeutic target for liver fibrosis
Yan Ning, Xinyue Dou, Zhichao Wang, et al.
Pharmacology & Therapeutics (2024) Vol. 257, pp. 108639-108639
Closed Access | Times Cited: 8

Alveolar cells under mechanical stressed niche: critical contributors to pulmonary fibrosis
Juntang Yang, Xin Pan, Lan Wang, et al.
Molecular Medicine (2020) Vol. 26, Iss. 1
Open Access | Times Cited: 54

Novel Strategies to Target Mast Cells in Disease
Aida Paivandy, Gunnar Pejler
Journal of Innate Immunity (2021) Vol. 13, Iss. 3, pp. 131-147
Open Access | Times Cited: 52

Differentiation of the tumor microenvironment: are CAFs the Organizer?
Marina Kochetkova, Michael S. Samuel
Trends in Cell Biology (2021) Vol. 32, Iss. 4, pp. 285-294
Closed Access | Times Cited: 47

Fibrosis and bone marrow: understanding causation and pathobiology
Kanjaksha Ghosh, Durjoy K. Shome, Bipin Kulkarni, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 17

Mast Cells in Cardiovascular Disease: From Bench to Bedside
Maud A.W. Hermans, Jeanine E. Roeters van Lennep, Paul Van Daele, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 14, pp. 3395-3395
Open Access | Times Cited: 52

Mast Cell Tryptase Promotes Inflammatory Bowel Disease–Induced Intestinal Fibrosis
Bin Liu, Muqing Yang, Tianyu Yu, et al.
Inflammatory Bowel Diseases (2020) Vol. 27, Iss. 2, pp. 242-255
Closed Access | Times Cited: 49

Mast Cells in Liver Fibrogenesis
Ralf Weiskirchen, Steffen K. Meurer, Christian Liedtke, et al.
Cells (2019) Vol. 8, Iss. 11, pp. 1429-1429
Open Access | Times Cited: 48

Novel airway smooth muscle–mast cell interactions and a role for the TRPV4-ATP axis in non-atopic asthma
Sara J. Bonvini, Mark A. Birrell, Eric Dubuis, et al.
European Respiratory Journal (2020) Vol. 56, Iss. 1, pp. 1901458-1901458
Open Access | Times Cited: 47

Innate Immunity Effector Cells as Inflammatory Drivers of Cardiac Fibrosis
Denisa Baci, Annalisa Bosi, Luca Parisi, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7165-7165
Open Access | Times Cited: 46

Leukocyte-Dependent Regulation of Cardiac Fibrosis
Ama Dedo Okyere, Douglas G. Tilley
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 39

Innate Immune Cells in Pressure Overload-Induced Cardiac Hypertrophy and Remodeling
Xin Liu, Guo‐Ping Shi, Junli Guo
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 38

Allergic Aspects of IgG4-Related Disease: Implications for Pathogenesis and Therapy
Despina Michailidou, Daniella M. Schwartz, Tomas Mustelin, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 34

Page 1 - Next Page

Scroll to top